← Back to Clinical Trials
Recruiting NCT07646782

NCT07646782 Human Observatory Study

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07646782
Status Recruiting
Phase
Sponsor Longevity Metrics, Inc.
Condition Aging
Study Type OBSERVATIONAL
Enrollment 1,000,000 participants
Start Date 2026-04-25
Primary Completion 2099-12-31

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
Multi-Domain Ecological and Clinical Data Linkage

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 1,000,000 participants in total. It began in 2026-04-25 with a primary completion date of 2099-12-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The Human Observatory Study is a prospective observational and ecological surveillance study building a continuously-updating world model for human health, disease, and death at the individual and population level. Individual multi-system clinical data from enrolled participants are linked to a continuously-ingested ecological data infrastructure spanning environmental exposures, social determinants, genealogical and family history records, mortality data, and population health databases at geographic resolutions from home address to global scale and beyond. The resulting model generates individual screening recommendations informed by population-level causal estimates, and population-level causal forecasts anchored by present-timepoint individual clinical biology. Thus creating a feedback architecture designed to improve both simultaneously.

Eligibility Criteria

Inclusion Criteria: * Enrolled in the 100-Year Human Aging Study at any fixed or mobile clinical site; OR completion of online health screener with provision of geographic anchor data and consent. Exclusion Criteria: * Age under 18 years (current protocol; pediatric amendment planned).

Contact & Investigator

Central Contact

William Brandenburg, MD

✉ info@longevitymetrics.org

📞 13035010016

Principal Investigator

William Brandenburg, MD

PRINCIPAL INVESTIGATOR

Longevity Metrics

Frequently Asked Questions

Who can join the NCT07646782 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Aging. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07646782 currently recruiting?

Yes, NCT07646782 is actively recruiting participants. Contact the research team at info@longevitymetrics.org for enrollment information.

Where is the NCT07646782 trial being conducted?

This trial is being conducted at Boulder, United States.

Who is sponsoring the NCT07646782 clinical trial?

NCT07646782 is sponsored by Longevity Metrics, Inc.. The principal investigator is William Brandenburg, MD at Longevity Metrics. The trial plans to enroll 1,000,000 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology